Dosage-related nature of escitalopram treatment-emergent mania/hypomania: a case series

QR Code

Dosage-related nature of escitalopram treatment-emergent mania/hypomania: a case series

Yasunari Yamaguchi, Sohei Kimoto, Takeshi Nagahama, Toshifumi Kishimoto Department of Psychiatry, Nara Medical University School of Medicine, Kashihara, Japan Objective: Several studies have documented that treatment with various antidepressant agents can result in mood switching during major depr...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Yamaguchi Y, Kimoto S, Nagahama T, Kishimoto T
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2018
Sujets:	Selective serotonin reuptake inhibitor (SSRI) escitalopram antidepressant treatment-emergent mania/hypomania dosage-related bipolar depression Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Accès en ligne:	https://doaj.org/article/3daa9ae2d03d4d9dbfc1423f34e786a9
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Selective serotonin reuptake inhibitors may lead to improved cataract surgery outcomes in patients with amblyopia
par: Xin KZ, et autres
Publié: (2019)

Pharmacogenetically Guided Escitalopram Treatment for Pediatric Anxiety Disorders: Protocol for a Double-Blind Randomized Trial
par: Jeffrey R. Strawn, et autres
Publié: (2021)

Long-term administration of escitalopram in patients with social anxiety disorder in Japan
par: Asakura S, et autres
Publié: (2016)

Noradrenaline plays a critical role in the switch to a manic episode and treatment of a depressive episode
par: Kurita M
Publié: (2016)

Effects of Celecoxib Adjunct to Selective Serotonin Reuptake Inhibitors on Obsessive-Compulsive Disorder
par: Najmeh Shahini, et autres
Publié: (2021)

A Pilot Study Differentiating Recurrent Major Depression from Bipolar Disorder Cycling on the Depressive Pole [Expression of Concern]
par: Hinz M, et autres
Publié: (2020)

A Pilot Study Differentiating Recurrent Major Depression from Bipolar Disorder Cycling on the Depressive Pole [Retraction]
par: Hinz M, et autres
Publié: (2020)

Mania and bipolar depression: complementing not opposing poles—a post-hoc analysis of mixed features in manic and hypomanic episodes
par: Christoph Born, et autres
Publié: (2021)

Effect of Depression and Antidepressants on Sexual Dysfunction in Men with Diabetes: A National Population-Based Cohort Study
par: Chung PL, et autres
Publié: (2020)

Mania following ketamine abuse
par: Lu YY, et autres
Publié: (2016)

A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials
par: Zhong Z, et autres
Publié: (2017)

Early symptom non-improvement and aggravation are associated with the treatment response to SSRIs in MDD: a real-world study
par: Yuan H, et autres
Publié: (2019)

Diagnóstico diferencial entre manía y déficit atencional hiperactivo
par: MARTÍNEZ A,JUAN CARLOS, et autres
Publié: (2007)

Escitalopram, bupropion, lurasidone, lamotrigine and possible vortioxetine overdose presented with serotonin syndrome and diffuse encephalopathy: A case report
par: Suthimon Thumtecho, et autres
Publié: (2021)

Does early improvement in depressive symptoms predict subsequent remission in patients with depression who are treated with duloxetine?
par: Sueki A, et autres
Publié: (2016)

The role of new antidepressants in clinical practice in Canada: a brief review of vortioxetine, levomilnacipran ER, and vilazodone
par: McIntyre RS
Publié: (2017)

Possible sertraline-induced extrapyramidal adverse effects in an adolescent
par: Wang LF, et autres
Publié: (2016)

An overview of mice models: a key for understanding subtypes of mania
par: Jorge Mauricio Cuartas Arias, et autres
Publié: (2016)

An observational study of duloxetine versus SSRI monotherapy in Japanese patients with major depressive disorder: subgroup analyses of treatment effectiveness for pain, depressive symptoms, and quality of life
par: Kuga A, et autres
Publié: (2017)

A Case Report of Opioid Induced Hypomania and Obsessive Compulsive Disorder
par: SH Hashemi, et autres
Publié: (2019)

Orexin/Hypocretin Type 2 Receptor (HCRTR2) Gene as a Candidate Gene in Sertraline-Associated Insomnia in Depressed Patients
par: Firouzabadi N, et autres
Publié: (2020)

A meta-analysis on the efficacy and safety of St John's wort extract in depression therapy in comparison with selective serotonin reuptake inhibitors in adults
par: Cui YH, et autres
Publié: (2016)

Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial
par: Kishi T, et autres
Publié: (2017)

The efficacy of vitamin B6 as an adjunctive therapy to lithium in improving the symptoms of acute mania in patients with bipolar disorder, type 1; a double‐blind, randomized, placebo‐controlled, clinical trial
par: Rahim Badrfam, et autres
Publié: (2021)

Lithium in late-life mania: a systematic review
par: De Fazio P, et autres
Publié: (2017)

Geophagia: A case series
par: Ichpreet Singh, et autres
Publié: (2021)

Application of a Conducting Poly-Methionine/Gold Nanoparticles-Modified Sensor for the Electrochemical Detection of Paroxetine
par: Saedah R. Al-Mhyawi, et autres
Publié: (2021)

The relationship of SSRI and SNRI usage with interstitial lung disease and bronchiectasis in an elderly population: a case–control study
par: Rosenberg T, et autres
Publié: (2017)

Valproate Reverses Mania-Like Behavior of Clockdelta19 Mouse and Alters Monoamine Neurotransmitters Metabolism in the Hippocampus
par: Liu S, et autres
Publié: (2021)

Encapsulated Escitalopram and Paroxetine Intranasal Co-Administration: In Vitro/In Vivo Evaluation
par: Soraia Silva, et autres
Publié: (2021)

Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies
par: Wigal SB, et autres
Publié: (2020)

Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review
par: Maneeton B, et autres
Publié: (2018)

The noradrenergic paradox: implications in the management of depression and anxiety
par: Montoya A, et autres
Publié: (2016)

Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia
par: Novick D, et autres
Publié: (2016)

Safety and effectiveness of escitalopram in an 8-week open study in Chinese patients with depression and anxiety
par: Wang G, et autres
Publié: (2018)

Optimized regimens of combined medications for the treatment of major depressive disorder: a double-blind, randomized-controlled trial
par: Zuilhof Z, et autres
Publié: (2018)

Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT
par: Larisa Duffy, et autres
Publié: (2021)

Validation of a quick and simple chromatographic method for simultaneous quantification of sertraline, escitalopram, risperidone and paliperidone levels in the human plasma
par: Jeremić Aleksandra, et autres
Publié: (2021)

Lithium Preparations in Psychiatry, Addiction Medicine and Neurology (To the 70th Anniversary of John Cade’s Discovery). Part I. History
par: Roman A. Bekker, et autres
Publié: (2019)

Risky decision-making following prefrontal D1 receptor manipulation
par: Beyer Dominik K. E., et autres
Publié: (2021)